Search Results - "Baba E"

A unified platform for nucleoside analog synthesis.

Authors: Anketell, Matthew J. Fung, Ethan Liu, Wenbin et al.

Source: Science. 5/14/2026, Vol. 392 Issue 6799, p1-8. 8p.

Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.

Authors: Shirakawa T Makiyama A Shimokawa M et al.

Source: Scientific reports [Sci Rep] 2024 Mar 04; Vol. 14 (1), pp. 5311. Date of Electronic Publication: 2024 Mar 04.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE

Reconstructive Challenges in Nasal Defects.

Authors: Baba, Umar Farooq Nissar, Yawar Wani, Adil Hafeez et al.

Source: Indian Journal of Plastic Surgery. 2025 Supplement 1, Vol. 58, pS5-S148. 144p.

Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST).

Authors: Kito Y Yamazaki K Shoji H et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 02; Vol. 238, pp. 116688. Date of Electronic Publication: 2026 Mar 19.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Comparative Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022.

Authors: Yokoe T Yoshinami T Nozawa K et al.

Source: International journal of clinical oncology [Int J Clin Oncol] 2025 Apr; Vol. 30 (4), pp. 674-683. Date of Electronic Publication: 2025 Feb 12.

Publication Type: Journal Article; Systematic Review; Meta-Analysis

Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Study protocol of the C-SOLVE (JACCRO GC-12) trial; a randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in HER2-negative, CLDN18.2-positive unresectable advanced gastric or esophagogastric junction cancer.

Authors: Yuki S Kawakami H Harada K et al.

Source: BMC cancer [BMC Cancer] 2026 Jul 17. Date of Electronic Publication: 2026 Jul 17.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Liquid biopsy for breast cancer and other solid tumors: a review of recent advances.

Authors: Ohmura H Hanamura F Okumura Y et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2025 Jan; Vol. 32 (1), pp. 33-42. Date of Electronic Publication: 2024 Mar 16.

Publication Type: Journal Article; Review

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

Versatility of Key Stone Flaps.

Authors: Baba, P. Umar Farooq¹ (AUTHOR)

Source: Indian Journal of Plastic Surgery. 2025 Supplement 1, Vol. 58, pS5-S148. 144p.

Post-Burn Hand Deformities.

Authors: Baba, P. Umar Farooq¹ (AUTHOR)

Source: Indian Journal of Plastic Surgery. 2025 Supplement 1, Vol. 58, pS5-S148. 144p.

Evaluation of the Analytical Performance of the STANDARD Q COVID‐19 Antigenic Test in Suspected COVID‐19 Cases in Bobo‐Dioulasso, Burkina Faso.

Authors: Sawadogo, Yacouba Ilboudo, Aicha Sombie, Herman Karim et al.

Source: BioMed Research International. 2/5/2026, Vol. 2026, p1-7. 7p.

Implementation Benchmark of Tumor-Agnostic Eligibility Signals Across Routine Comprehensive Genomic Profiling Platforms in Japan: A Nationwide C-CAT Analysis.

Authors: Kajiura, Shinya Nakamura, Naohiko Hayashi, Ryuji

Source: Current Oncology. Jun2026, Vol. 33 Issue 6, p324. 10p.

Microbiological Investigations of Bacteria Infecting Yolks of Broiler and Broiler Breeder Embryos and Hatchlings.

Authors: Lawal, Aishat Perry, Chelse Oduola, Abass et al.

Source: Poultry. Jun2026, Vol. 5 Issue 3, p39. 11p.

Observed RET-Positive Findings Across Routine Comprehensive Genomic Profiling Platforms in Japan: A Nationwide Descriptive Benchmark.

Authors: Kajiura, Shinya Hayashi, Ryuji

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1735. 14p.

Artificial Intelligence for Tumor Tissue Detection in Stomach Cancer: A Retrospective Algorithm Development and Validation Study.

Authors: Karnaukhov, Nikolay Palumbo, Vincenzo Davide Voloshin, Mark et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 9, p3370. 25p.

Safety and Efficacy of FOLFIRI-3 (Split-Dose Irinotecan) for Unresectable Colorectal Cancer: A Stratified Analysis Based on UGT1A1 Gene Polymorphisms.

Authors: Ohira, Gaku Miyauchi, Hideaki Tochigi, Toru et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1377. 13p.

Author Index.

Source: Digestive Endoscopy. Feb2020 Supplement S1, Vol. 32, p257-271. 15p.

A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.

Authors: Baba K Suzuki N Imamura CK et al.

Source: BMC cancer [BMC Cancer] 2025 Apr 12; Vol. 25 (1), pp. 675. Date of Electronic Publication: 2025 Apr 12.

Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Novel SrSnO 3 /AgBr Heterojunction for Dye Degradation Under Simulated Sunlight.

Authors: Tian-Wu, Si-Hao Liu, Shi-Mei Zhong, Yan et al.

Source: Inorganics. Dec2025, Vol. 13 Issue 12, p406. 12p.

A widespread chronic pruritic varioliform ulcerating eruption.

Authors: McGrath, Conn Tull, Thomas J Markiewicz, Dorota et al.

Source: Clinical & Experimental Dermatology. May2025, Vol. 50 Issue 5, p1063-1065. 3p.

BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).

Authors: Taniguchi, Hiroya Uehara, Kay Ishikawa, Toshiaki et al.

Source: Cancers. Feb2025, Vol. 17 Issue 3, p399. 15p.